News
A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...
A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback